Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer.
Mol Ther Oncolytics. 2020 Sep 2;19:57-66. doi: 10.1016/j.omto.2020.08.020. eCollection 2020 Dec 16.
Mol Ther Oncolytics. 2020.
PMID: 33072863
Free PMC article.
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.
Béguin J, Nourtier V, Gantzer M, Cochin S, Foloppe J, Balloul JM, Laloy E, Tierny D, Klonjkowski B, Quemeneur E, Maurey C, Erbs P.
Béguin J, et al. Among authors: nourtier v.
BMC Vet Res. 2020 Aug 25;16(1):307. doi: 10.1186/s12917-020-02524-y.
BMC Vet Res. 2020.
PMID: 32843040
Free PMC article.
Item in Clipboard
By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P, Remy-Ziller C, Winter E, Gantzer M, Nourtier V, Kempf J, Hortelano J, Schmitt D, Schultz H, Geist M, Brua C, Hoffmann C, Schlesinger Y, Villeval D, Thioudellet C, Erbs P, Foloppe J, Silvestre N, Fend L, Quemeneur E, Marchand JB.
Kleinpeter P, et al. Among authors: nourtier v.
J Virol. 2019 May 15;93(11):e00207-19. doi: 10.1128/JVI.00207-19. Print 2019 Jun 1.
J Virol. 2019.
PMID: 30918073
Free PMC article.
Item in Clipboard
Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model.
Remy-Ziller C, Thioudellet C, Hortelano J, Gantzer M, Nourtier V, Claudepierre MC, Sansas B, Préville X, Bendjama K, Quemeneur E, Rittner K.
Remy-Ziller C, et al. Among authors: nourtier v.
Hum Vaccin Immunother. 2018 Jan 2;14(1):140-145. doi: 10.1080/21645515.2017.1373921. Epub 2017 Oct 18.
Hum Vaccin Immunother. 2018.
PMID: 28925793
Free PMC article.
Item in Clipboard
Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.
Ramos RN, Tosch C, Kotsias F, Claudepierre MC, Schmitt D, Remy-Ziller C, Hoffmann C, Ricordel M, Nourtier V, Farine I, Laruelle L, Hortelano J, Spring-Giusti C, Sedlik C, Le Tourneau C, Hoffmann C, Silvestre N, Erbs P, Bendjama K, Thioudellet C, Quemeneur E, Piaggio E, Rittner K.
Ramos RN, et al. Among authors: nourtier v.
Clin Transl Immunology. 2022 May 8;11(5):e1392. doi: 10.1002/cti2.1392. eCollection 2022.
Clin Transl Immunology. 2022.
PMID: 35573979
Free PMC article.
Item in Clipboard
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC.
Tosch C, Bastien B, Barraud L, Grellier B, Nourtier V, Gantzer M, Limacher JM, Quemeneur E, Bendjama K, Préville X.
Tosch C, et al. Among authors: nourtier v.
J Immunother Cancer. 2017 Sep 19;5(1):70. doi: 10.1186/s40425-017-0274-x.
J Immunother Cancer. 2017.
PMID: 28923084
Free PMC article.
Clinical Trial.
Item in Clipboard
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.
Fend L, Yamazaki T, Remy C, Fahrner C, Gantzer M, Nourtier V, Préville X, Quéméneur E, Kepp O, Adam J, Marabelle A, Pitt JM, Kroemer G, Zitvogel L.
Fend L, et al. Among authors: nourtier v.
Cancer Res. 2017 Aug 1;77(15):4146-4157. doi: 10.1158/0008-5472.CAN-16-2165. Epub 2017 May 23.
Cancer Res. 2017.
PMID: 28536278
Item in Clipboard
Cite
Cite